New focus on adverse impact of male factors in assisted reproductive treatments
May 17 2021
The adverse impact of male factors in assisted reproductive treatments was brought into a clear and disturbing focus at the 10
th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE).
The ASPIRE Congress, originally to be held in the Philippines, is being presented in virtual format – https://aspire2021.cme-congresses.com – to on-line participants in more than 100 countries because of ongoing concerns about COVID-19.
Professor Peter Schlegel from the Centre of Reproductive Medicine at New York s Weill Cornell Medical College, cast new light on sperm quality, the source of sperm for assisted conception – either from testicular, epididymal or ejaculate – male obesity and paternal age in the success of fertility treatment.
New insights into how AI will lead to developments in assisted reproductive technology
The 10
th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) has provided exciting insights into likely developments and future possibilities in assisted reproductive technology including artificial intelligence.
Since the first IVF baby was born in 1978, more than eight million babies have been delivered as a result of the assisted reproductive technique.
In that time, there have been amazing advances in technology and treatment protocols to help the one in six couples living with infertility to fulfil their dreams of parenthood. One child in every 20 born today is an IVF baby, and another five per cent of babies around the world are conceived with the help of fertility drugs.
Monday, 10 May 2021, 5:19 pm
SINGAPORE, May 10, 2021 /PRNewswire/ The first births
and on-going well-being of babies born from an advanced
assisted reproduction process called CAPA in-vitro oocyte
maturation, or IVM, has highlighted the potential of the
procedure for millions of women with complex fertility
issues including polycystic ovarian syndrome
(PCOS).
IVM is a technique to obtain oocytes that are
developed in vitro prior to fertilisation with sperm in a
laboratory with an embryo transferred back into a patient s
uterus with the aim of an ongoing pregnancy and live
birth.
A major benefit of IVM is that it requires
minimal hormonal stimulation of the ovaries that is a
SINGAPORE, May 8, 2021 /PRNewswire/ Mounting concerns about access to infertility treatment in low to middle income countries and measures to address the problem have come into sharp focus at the 10th Congress of the Asia Pacific Initiative on Reproduction .